Focuses on the interaction between scientists concerning a study on the effects of the antiestrogens tamoxifen on endometrial cancer growth and on the therapeutic targeting of transcription in acute promyelocytic leukemia. Overview of both studies; Implication of the results; Arguments raised by the scientists.